Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Denmeade

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Prostate|May 27, 1999
Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cellsS R Denmeade, X S Lin, B Tombal, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2016
The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancerB A Teply, B Luber, S R Denmeade, et al.
Cell Death and Differentiation|April 26, 2002
A supramicromolar elevation of intracellular free calcium ([Ca(2+)](i)) is consistently required to induce the execution phase of apoptosisB Tombal, S R Denmeade, J-M Gillis, et al.
Endocrine-Related Cancer|September 7, 2006
Combinatorial androgen receptor targeted therapy for prostate cancerP Singh, A Uzgare, I Litvinov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissueI B Joseph, J B Nelson, S R Denmeade, et al.
The Prostate|July 4, 2001
Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessingS R Denmeade, J Lövgren, S R Khan, et al.
The Journal of Urology|June 7, 2000
Complete androgen blockade for prostate cancer: what went wrong?M Laufer, S R Denmeade, V J Sinibaldi, et al.
Cancer Research|November 14, 1997
Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigenS R Denmeade, W Lou, J Lövgren, et al.
The Prostate|June 8, 2001
Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft modelsS R Denmeade, L J Sokoll, D W Chan, et al.
Cancer Research|July 4, 1998
Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigenS R Denmeade, A Nagy, J Gao, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Prostate|May 27, 1999
Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cellsS R Denmeade, X S Lin, B Tombal, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2016
The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancerB A Teply, B Luber, S R Denmeade, et al.
Cell Death and Differentiation|April 26, 2002
A supramicromolar elevation of intracellular free calcium ([Ca(2+)](i)) is consistently required to induce the execution phase of apoptosisB Tombal, S R Denmeade, J-M Gillis, et al.
Endocrine-Related Cancer|September 7, 2006
Combinatorial androgen receptor targeted therapy for prostate cancerP Singh, A Uzgare, I Litvinov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissueI B Joseph, J B Nelson, S R Denmeade, et al.
The Prostate|July 4, 2001
Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessingS R Denmeade, J Lövgren, S R Khan, et al.
The Journal of Urology|June 7, 2000
Complete androgen blockade for prostate cancer: what went wrong?M Laufer, S R Denmeade, V J Sinibaldi, et al.
Cancer Research|November 14, 1997
Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigenS R Denmeade, W Lou, J Lövgren, et al.
The Prostate|June 8, 2001
Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft modelsS R Denmeade, L J Sokoll, D W Chan, et al.
Cancer Research|July 4, 1998
Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigenS R Denmeade, A Nagy, J Gao, et al.
Pageof 4